Effective Strategies in Developing Accelerator Models April 22, 2013 Richard A. Bendis President & CEO BioHealth Innovation, Inc.
The Region: Central Maryland Unrivaled Research Assets 59 Federal Laboratories, Centers, and Institutes Annual Maryland R&D Investment Federal: $12 billion JHU/USM: $3.5 billion
An Innovation Intermediary Technology Align local technologies, assets and resources Focus to advance innovation E-Health Regionally-oriented Therapeutics Mobile Health Private-public partnership Medical Devices 501(c)(3) nonprofit Healthcare Services Market-driven Electronic Medical Records BioHealth Cyber Security Private sector-led Health Informatics Diagnostics
Partners and Sponsors
BHI Commercialization Model PUBLICATIONS PhD's UNIVERSITIES, FEDERAL GRANTS, PRIVATE R&D, BASIC RESEARCH, INVENTIONS TENURE PATENTS REINVESTMENT PROOF OF 1 CONCEPT 2 10 PRODUCT DEVELOPMENT NEXT GENERATION RESEARCH PRODUCTS 3 9 8 4 PROTOTYPE GENERATE EQUITY, PRODUCT ROYALITIES, & LICENSE FEES 7 5 PROOF OF 6 COMMERCIAL TRANSFER WEALTH CREATION: SPINOFF MAKE TECHNOLOGY RELEVANCE FUNDING & TECHNOLOGY COMPANIES, JOBS, PRODUCTS COMPANIES INVESTMENT GRADE ENTREPRENEURIAL TO INDUSTRY & PROFITS RESOURCES
Innovation Paradigm Shift Proof of PROOF OF CONCEPT COMMERCIAL RELEVANCE (Technological Feasibility) (Market Pull) Laboratory Push “It Works To Solve A Problem” “It Works!” “I’ll Buy It” $
What is an Entrepreneur in Residence? An active partner with research institutions Todd 13 Years Scientific 4 Years Financial / Venture Capital Chappell 13 Years Entrepreneurial Management
Our Entrepreneur in Residence: Todd Chappell + 30 NIH Postdocs and Interns Transfer / Identify Evaluate Startup Drugs Vaccines Health IT Diagnostics Therapeutics Medical Devices
NIH/OTT: First Year Outcomes 97 63 12 Innovations Innovations Innovations in identified progressed Primary Analysis 5 Client Relationships 1 NCI Startup 1 Industry License Pending
Client Companies Advanced Personalized Diagnostics, LLC Personalized Offers chemosensitivity profiling services to provide Cancer Care personalized treatment plans Ahead Research, Inc. Personalized Web/Mobile application that matches patients to high Diagnostics quality healthcare providers Mimetas Organ-on-a-Chip solutions as an early screening model to Pharmaceutical predict toxic side effects and drug efficacy Perceptive Navigation, LLC Develops medical devices related to image-guided, Medical Device minimally-invasive markets
National Institutes of Health University of Maryland Ventures EIR National Heart Lung and Blood Institute National Cancer Institute Health Information Technology EIR Industry EIR Potential Future EIR Expansion
Innovation Capital Valley of Death Pre-Seed Seed/Start-Up Early Later Stage Founders, FFF, Angels, IBED, SBIR, Accelerator Seed Venture Funds, Bootstrapping, Funds M&A, IPO Crowdfunding Source $0K $500K $2.5M $5.0M Demand VALLEY OF DEATH Supply Funding Gap
Innovation Capital Programs SBIR/STTR Assistance Program Help companies prepare high-quality SBIR/STTR grant proposals. BHI Angel Fund Bridge the gap between pre-seed investments and institutional venture capital. BHI Commercial Relevance Investment Fund Pre-seed and early-stage, equity-based innovation capital fund to help grow companies
New BHI Health IT Accelerator An intensive 16-week program for top-recruited companies and entrepreneurs Provides a network of experienced mentors in: Business Marketing Product Development No HIT accelerators currently in Maryland
Public Private Partnerships ACADEMIA INDUSTRY • R ESEARCH /T2 • P ROFIT • L IFELONG L EARNING • P ROCESS • E CONOMIC D EVELOPMENT • P RODUCT INSEPARABLE MISSIONS GOVERNMENT FOUNDATIONS • S USTAINABILITY • E CONOMIC G ROWTH • I NFRASTRUCTURE SUPPORT • C OMMUNITY INVESTMENT • E CONOMIC POLICY • R EGIONAL COLLABORATION
Richard A. Bendis President & CEO Cell: (215) 594-3333 Office: (301) 637-6439 Email: rbendis@bendisig.com ” The BHI EIR program represents a significant paradigm shift in the way NIH hopes to advance commercially relevant science. ”
Recommend
More recommend
